Institutional investors control 44.40% of the outstanding shares in GERN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended December 2014, these large investors purchased a net $6.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OPALEYE MANAGEMENT, INC. Bought 1.0 Million shares of Geron Corp
RENAISSANCE TECHNOLOGIES LLC Bought 429.9 Thousand shares of Geron Corp
TWO SIGMA INVESTMENTS LLC Bought 423.3 Thousand shares of Geron Corp